CXCL13 and neoplasm: The tumor-reactive T-cell signature identified by Lowery et al. [39] (Supplementary Table 5) was enriched in CD8+_CXCL13 (cluster 0) and CD8+_MKI67 (cluster 8) (Supplementary Fig. 13C; Supplementary Table 6).